Comphya developing an active implantable medical device to restore the erectile function of patient non-responsive to oral drugs.
Comphya has raised €9.9M across 3 funding rounds from 2 investors, most recently a Series A round in Jul 2025. Based in Zurich, Switzerland; founded 2017; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-07-08 | Series A | €8.0M | — | View deal → |
| 2023-01-31 | Debt | €847k | Existing investors,Praxis Spinal Cord Institute | View deal → |
| 2020-12-02 | Seed | €1.1M | — | View deal → |
